Global Medical Director, Riliprubart

Role Summary

Global Medical Director, riliprubart, based in Cambridge, MA. Lead the medical strategy for riliprubart across the product value chain, drive evidence generation and medical education plans, and partner with cross-functional teams to advance understanding of CIDP and riliprubart among global external stakeholders. Oversee medical programs and investigations and ensure scientific integrity of internal and external medical materials while managing budget adherence and cross-functional alignment.

Responsibilities

• Co-develop, plan and lead the execution of the medical strategy for riliprubart across the product value chain.
• Co-create the IEGP strategy with Medical Evidence Generation Lead and other evidence generation-related functions: Clinical Study Unit (CSU), Real World Evidence (RWE), Health Economics Outcomes Research (HEVA), Medical Operations and Effectiveness (MO&E) and country teams.
• Lead the execution of assigned medical affairs studies (EAP). Provide input in design, monitoring, analysis, and communication of the assigned studies. Serve as a global medical point of contact for such studies for internal and external stakeholders.
• Contribute to insight generation plan and input to the assigned asset's overall medical strategy.
• Provide strategic input to Scientific Communications team to plan and execute evidence dissemination and medical education plans.
• Build trust with global external stakeholders to advance their understanding of the therapeutic area and evolve the treatment landscapes for CIDP and riliprubart.
• Oversee the design of medical programs/initiatives to drive the therapeutic value of riliprubart and address unmet medical needs (i.e., MAPs, PSP, Diagnostic support programs, CSRs, etc).
• Oversee adherence to allocated budgets, plan and execute activities aligned with strategy and smart execution principles to assure prioritization and cross-functional alignment.
• Accountable for medical affairs review and scientific integrity of internal and external medical materials.

Qualifications

• Required: Minimum of 4 years’ experience in relevant Medical Affairs.
• Preferred: Deep expertise in Neurology & Neuromuscular Diseases.
• Preferred: Demonstrated industry experience in strategic roles from medical affairs or clinical development related areas including scientific KOL engagement, evidence generation and scientific communication at Global and Key Market level.
• Required: Broad drug development experience with robust knowledge of regulatory, market access and reimbursement.
• Preferred: Demonstrated experience in managing clinical trials in a pharmaceutical environment.
• Preferred: Demonstrated specialty care product launch experience at a country level.
• Preferred: Significant line and matrix management experience, including collaboration with Research, Clinical Development, Commercial, Health Economics, Value and Access and Product Management functions.

Skills

• Strategic thinking: ability to disrupt status quo with innovation while remaining pragmatic and focused on priorities.
• Result orientation: ability to develop and execute optimal strategy meeting corporate objectives, while creating pragmatic solutions. Comfortable with ambiguity and able to adapt with agility, take calculated risks and anticipate potential issues.
• People Leadership: ability to engage and leverage everyone’s strengths while being highly self-aware. Set high standards and expectations, communicates proactively, collaborative and approachable; able to provide meaningful feedback, coaching and support.
• Relationships and Influence: effective stakeholder management, and role model for collaboration and teamwork.
• Highest ethical, regulatory and scientific standards.

Education

• Education: Doctorate in relevant scientific discipline or Pharmacy – Medical Degree preferred
• Languages: Fluent in English